Acadia: Q2 Earnings Snapshot

Acadia Pharmaceuticals reported second-quarter profit of $31.5 million, or 18 cents per share, exceeding the 6 cents per share estimate. The company's revenue reached $308 million, surpassing forecasts of $293.8 million, with a full-year revenue forecast of $1.24 billion to $1.3 billion. Shares have risen 1% since the start of the year and hit $27, reflecting a 12% increase in the last 12 months.